The Big Pharma Lie & Attack on JFK Jr

Why do you think Big Pharma, the NYT and 75 Nobel laureates are

 Attacking JFK Jr?

According to OpenSecrets, the pharmaceutical and health products industry — including not only drug manufacturers but also dealers of medical products and nutritional and dietary supplements — is consistently near the top of all spenders when it comes to federal campaign contributions and lobbying spending. The industry has had a boon of federal campaign contributions and lobbying expenditures due to the COVID-19 pandemic and vaccination effort. Drug manufacturers, medical product dealers and those dealing with supplements have spent huge amounts of money to lobby the federal government as its products, like vaccines and new treatments that have been developed in a short period of time, have been used to try and ease the pandemic. (Pharmaceutical manufacturers are a subset of this industry and are profiled in detail within this section).

The industry's political contributions increased in the years leading up to Congress' passage in 2003 of a Medicare prescription drug benefit and soared following passage of the Affordable Care Act (aka “Obamacare”) in 2010. 

That year also saw contributions to super PACs and other outside spending groups grow, following the Supreme Court’s decision in Citizens United v FEC. Contributions from the pharmaceutical and health products industry jumped in each presidential election cycle since 2012, reaching $89,091,362 in 2020 — a 170% increase from a decade prior

Exhibit A:  NYT aka The Pusher:

Big Pharma Brings out the Big Guns. Like Soros, the NYT with its right hand, covers what its left hand is doing; The Nobel laureates are the same ones who declared people could not travel without a Covid-19 passport- that same hand pushes Ozempic 

The right hand says there's conflict of interest among drug pushers:

NYT: aka the Pusher

And the NYT wants to have it both ways 

Big Pharma Blames the Middleman

Big Pharma Annual Lobbying:  does not disclose quid-pro-quo with doctors or publications, such as the NYT Ozempic subliminal propaganda

Drug Disvovery and Development 

According to Statistica, In 2023, pharmaceutical companies AstraZeneca spent over 23 percent of its prescription drug revenues on research and development. In general, big pharmaceutical companies spend around 20 percent of their revenues on research and development.

Big Tech R&D Spending 

R & D World reports In 2023, the world’s top companies invested hefty sums in R&D, with tech giants like Amazon, Alphabet, and Meta leading the pack. Amazon alone poured $85.622 billion into technology and infrastructure, which includes R&D. A significant portion of the company’s investment is fueled by Amazon’s belief that generative AI, while still a small revenue generator today, will ultimately drive tens of billions of dollars of revenue across multiple business segments in the years ahead.


OpenSecrets reported that the number of entities lobbying on issues related to AI boomed in recent years, from single digits a decade ago to 30 in 2017 to 158 last year. Big Tech companies Amazon, Microsoft, Oracle, Google’s parent company Alphabet Inc., IBM and Meta were among those that reported lobbying on AI issues. Amazon, Apple, Google, Meta and Microsoft spent nearly $69 million lobbying the federal government in 2022.

Reform 230

The Computer and Communications Industry Association (CCIA) and NetChoice, wo tech industry groups representing several Big Tech companies including Facebook’s parent company, Meta, as well as Twitter and Alphabet Inc., the parent company of YouTube and Google were granted an emergency request for an injunction in NetChoice v. Paxton when the U.S. Supreme Court blocked a Texas law allowing the state’s residents and attorney general to sue social media companies over certain content moderation decisions. The Texas law would prohibit tech platforms from removing or restricting content based on “the viewpoint represented in the user’s expression.”  Texas Republicans passed the law to address perceived liberal bias of social media platforms amid growing concerns about the power of Silicon Valley and a flurry of state and federal legislative activity seeking to regulate Big Tech.   On top of big spending, NetChoice has leveraged the “revolving door” of former government officials, most recently hiring former Rep. Barbara Comstock (R-Va.) as a lobbyist.

The association has lobbied on a range of topics impacting the tech industry in 2022, including Section 230, copyright issues, online taxation, open internet, broadband deployment, encryption, data portability, skilled immigration and antitrust.